Dr. John E Seng M.D.
Hematologist-Oncologist | Hematology & Oncology
910 E 26th St Suite 200 Minneapolis MN, 55404About
Dr. John Seng is a hematologist oncologist practicing in Minneapolis, MN. Dr. Seng specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Univ of Mn Med Sch-Minneapolis, Minneapolis Mn 1992
University of Minnesota Medical School 1992
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- The effects of different levels of dietary restriction on aging and survival in the Sprague-Dawley rat: implications for chronic studies.
- Body weight considerations in the B6C3F1 mouse and the use of dietary control to standardize background tumor incidence in chronic bioassays.
- Toxicokinetics of chloral hydrate in ad libitum-fed, dietary-controlled, and calorically restricted male B6C3F1 mice following short-term exposure.
- Minimal toxicity of stabilized compacted DNA nanoparticles in the murine lung.
- The toxicity profile of hydrolyzed aqueous olive pulp extract.
- Cellular localization of cytochrome P450IIA1 in testes of mature Sprague-Dawley rats.
- Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 Pentetreotide.
- Effects of caloric restriction on rodent drug and carcinogen metabolizing enzymes: implications for mutagenesis and cancer.
- Purification and characterization of an amidase from an acrylamide-degrading Rhodococcus sp.
- Effects of caloric restriction on expression of testicular cytochrome P450 enzymes associated with the metabolic activation of carcinogens.
- FDA points-to-consider documents: the need for dietary control for the reduction of experimental variability within animal assays and the use of dietary restriction to achieve dietary control.
- Indolent B-cell non-Hodgkin's lymphomas.
- Low dose chemotherapy for myelodysplastic syndromes.
Treatments
- Liver Cancer
- Pancreatic Cancer
- Prostate Cancer
- Anemia
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Bile Duct Cancer
- Stomach Cancer
- Lymphoma
- Leukemia
- Lightpod Neo
- Extra Corporeal Shockwave Therapy
Dr. John E Seng M.D.'s Practice location
Minneapolis, MN 55404Get Direction
Dr. John E Seng M.D.'s reviews
Write ReviewPatient Experience with Dr. Seng
Recommended Articles
- The Link Between Lymphoma Radiotherapy and Mesothelioma
One of the more common forms of treatment for lymphoma is radiotherapy. This involves using radiation to kill the cancer cells in the lymph nodes. New studies have produced concerning findings regarding radiation therapy, and point towards another induced risk of using the practice.The StudyThe...
- A Triathlon for Bloodwise
Where would anyone be without friends? There have been many experiences where friends have been a bit of light in the dark. When 30-year-old Alexandra “Pixie” Flather from a town near Aylsham, England found out that her best friend was diagnosed with Leukemia, she decided to take action. At the...
- Morphos Declared a "Breakthrough Therapy" for Lymphoma
MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
- Can Multiple Myeloma be Asymptomatic?
Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...
- Microsoft Co-Founder Paul Allen Beats Lymphoma Twice
Beating any type of cancer is a major feat in itself, but billionaire and Microsoft co-founder Paul Allen has defeated lymphoma not once, but twice.Paul's storyNeedless to say, being the co-founder of Microsoft is a pretty big deal. As an American digital pioneer, Paul has been on top of the world....
- Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma Research
There’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...
Nearby Providers
- Dr. Mukta Arora M.B., B.S.516 Delaware Street Se Minneapolis MN 55455
- Dr. Naomi Fujioka MD500 Harvard St Se Minneapolis MN 55455
- Dr. Nelli Bejanyan M.D.516 DELAWARE ST SE MINNEAPOLIS MN 55455
- Dr. Matthew T Gall M.D.675 E Nicollet Blvd Burnsville MN 55337
- Dr. Zohar Sachs MD PHD420 Delaware St SE Minneapolis MN 55455
- Dr. John F Schwerkoske M.D.6025 Lake Rd Saint Paul MN 55125